Atique Uddin Ahmed

  • 2155 Citations
If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Research Interests

The focus of my laboratory research is to elucidate the mechanisms of therapeutic resistance in brain tumor. We are particularly interested in investigating the role of cellular plasticity in promoting the cancer stem cell niche and disease recurrence.

Training Experience

2009Postdoctoral Fellowship, Mayo Medical School

Education/Academic qualification

PhD, Mayo Medical School

… → 2007

Research interests

  • Bioengineering
  • Brain Cancer / Nervous System Cancer
  • Cancer Biology
  • Cancer Genetics
  • Cell Biology
  • Cell Imaging
  • Chemotherapy
  • Gene Therapy
  • Stem Cells

Fingerprint Dive into the research topics where Atique Uddin Ahmed is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 14 Similar Profiles
Glioma Medicine & Life Sciences
Glioblastoma Medicine & Life Sciences
Neural Stem Cells Medicine & Life Sciences
Brain Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Oncolytic Virotherapy Medicine & Life Sciences
Adenoviridae Medicine & Life Sciences
Stem Cells Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 2015 2023

Neoplastic Stem Cells
Disease Progression
Stem Cell Niche
Stem Cells
Drug Therapy
Stem Cells
Brain Neoplasms
Genetic Therapy
Stem Cells

Research Output 2001 2019

Activation of dopamine receptor 2 prompts transcriptomic and metabolic plasticity in glioblastoma

Caragher, S. P., Shireman, J. M., Huang, M., Miska, J. M., Atashi, F., Baisiwala, S., Park, C. H., Saathoff, M. R., Warnke, L., Xiao, T., Lesniak, M. S., James, C. D., Meltzer, H. Y., Tryba, A. K. & Ahmed, A. U., Mar 13 2019, In : Journal of Neuroscience. 39, 11, p. 1982-1993 12 p.

Research output: Contribution to journalArticle

Dopamine Receptors
Neurotransmitter Agents
Tumor Microenvironment

Diagnostic Clinical Trials in Breast Cancer Brain Metastases: Barriers and Innovations

Fares, J., Kanojia, D., Rashidi, A., Ahmed, A. U., Balyasnikova, I. V. & Lesniak, M. S., Jan 1 2019, In : Clinical breast cancer.

Research output: Contribution to journalReview article

Brain Neoplasms
Clinical Trials
Breast Neoplasms
Neoplasm Metastasis
Circulating Neoplastic Cells

FABP7 is a key metabolic regulator in HER2+ breast cancer brain metastasis

Cordero, A., Kanojia, D., Miska, J. M., Panek, W. K., Xiao, A., Han, Y., Bonamici, N., Zhou, W., Xiao, T., Wu, M., Ahmed, A. U. & Lesniak, M. S., Jan 1 2019, In : Oncogene.

Research output: Contribution to journalArticle

Brain Neoplasms
Breast Neoplasms
Neoplasm Metastasis
human ERBB2 protein

Glioblastoma Recurrence and the Role of O 6 -Methylguanine-DNA Methyltransferase Promoter Methylation

Storey, K., Leder, K., Hawkins-Daarud, A., Swanson, K., Ahmed, A. U., Rockne, R. C. & Foo, J., Feb 1 2019, In : JCO clinical cancer informatics. 3, p. 1-12 12 p.

Research output: Contribution to journalArticle

O(6)-Methylguanine-DNA Methyltransferase
2 Citations (Scopus)

HIF-1α Is a Metabolic Switch between Glycolytic-Driven Migration and Oxidative Phosphorylation-Driven Immunosuppression of Tregs in Glioblastoma

Miska, J. M., Lee Chang, C., Rashidi, A., Muroski, M. E., Chang, A. L., Lopez-Rosas, A., Zhang, P., Panek, W. K., Cordero, A., Han, Y., Ahmed, A. U., Chandel, N. & Lesniak, M. S., Apr 2 2019, In : Cell reports. 27, 1, p. 226-237.e4

Research output: Contribution to journalArticle

Open Access
Hypoxia-Inducible Factor 1
Oxidative Phosphorylation